<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-pharmaceuticals-12-00060">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Raboni</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Bonfim</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Almeida</surname>
    <given-names>B.M.</given-names>
   </name>
   <name>
    <surname>Zanluca</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Koishi</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Rodrigues</surname>
    <given-names>P.R.V.P.</given-names>
   </name>
   <name>
    <surname>Kay</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Ribeiro</surname>
    <given-names>L.L.</given-names>
   </name>
   <name>
    <surname>Scola</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>dos Santos</surname>
    <given-names>C.N.D.</given-names>
   </name>
  </person-group>
  <article-title>Flavivirus cross-reactivity in serological tests and Guillain-Barr√© syndrome in a hematopoietic stem cell transplant patient: A case report</article-title>
  <source>Transpl. Infect. Dis.</source>
  <year>2017</year>
  <volume>19</volume>
  <fpage>e12700</fpage>
  <pub-id pub-id-type="doi">10.1111/tid.12700</pub-id>
 </element-citation>
</ref>
